Loading…

Role of the neoadjuvant therapy in the treatment of advanced carcinoma of the esophagus

The aim of this study was to compare microscopically radical resection (R0) rate after surgery alone, preoperative chemotherapy, and preoperative chemo-/radiotherapy. Between 1992-1997, 101 patients were operated for squamous cell carcinoma of the esophagus. Thirty four patients were treated by surg...

Full description

Saved in:
Bibliographic Details
Published in:Contemporary oncology (Poznań, Poland) Poland), 2000-03, Vol.4 (2), p.80
Main Authors: Dabrowski, Andrzej, Wallner, Grzegorz, Misiuna, Pawel, Polkowski, Wojciech
Format: Article
Language:eng ; pol
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 2
container_start_page 80
container_title Contemporary oncology (Poznań, Poland)
container_volume 4
creator Dabrowski, Andrzej
Wallner, Grzegorz
Misiuna, Pawel
Polkowski, Wojciech
description The aim of this study was to compare microscopically radical resection (R0) rate after surgery alone, preoperative chemotherapy, and preoperative chemo-/radiotherapy. Between 1992-1997, 101 patients were operated for squamous cell carcinoma of the esophagus. Thirty four patients were treated by surgery alone, in 42 patients surgery followed preoperative chemotherapy with cisplatin (20 mg/m2/dobe; days: 1-5 i 17-21 days) and 5-FU (300 mg/m2/dobe; for 21 days). In 25 patients concurrently with chemotherapy, radiotherapy was applied in fractions (for 15 days) up to total dose of 3000 cGy. Postoperative mortality and morbidity was 15% and 50%, respectively. In the chemotherapy group, complete response (CR) rate was 4,8%, partial response (PR) was 80,9%, and stabile disease (SD) was observed in 14,3% of patients. In the chemo-/radiotherapy group the CR, PR, and SD rate were 8%, 80%, and 12%, respectively. The R0 resection rates after surgery alone, preoperative chemotherapy and chemo-/radiotherapy were 3%, 26%, and 40%, respectively. Conclusion: in patients with advanced squamous cell carcinoma of the esophagus, preoperative chemo- and/or radiotherapy improves microscopically radical resection rate, as compared to surgery alone.
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1237635816</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2840256811</sourcerecordid><originalsourceid>FETCH-proquest_journals_12376358163</originalsourceid><addsrcrecordid>eNqNjE0LgkAURYcoSMr_MNBaUEfHcR1F6whaxkufqeiMzUfQv2-K2re693IOd0aCRJRFlLG4nPuepSJK85QvSWhMd43jpBA5Zywg56MakKqG2hapRAV17x4g7XtrmJ60kx9kNYId0QPvQu2VCmtaga46qUb4PaBRUws3Z9Zk0cBgMPzmimz2u9P2EE1a3R0ae-mV09KjS5KygrNcJJz9Z70AEsBDuQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1237635816</pqid></control><display><type>article</type><title>Role of the neoadjuvant therapy in the treatment of advanced carcinoma of the esophagus</title><source>Publicly Available Content Database</source><creator>Dabrowski, Andrzej ; Wallner, Grzegorz ; Misiuna, Pawel ; Polkowski, Wojciech</creator><creatorcontrib>Dabrowski, Andrzej ; Wallner, Grzegorz ; Misiuna, Pawel ; Polkowski, Wojciech</creatorcontrib><description>The aim of this study was to compare microscopically radical resection (R0) rate after surgery alone, preoperative chemotherapy, and preoperative chemo-/radiotherapy. Between 1992-1997, 101 patients were operated for squamous cell carcinoma of the esophagus. Thirty four patients were treated by surgery alone, in 42 patients surgery followed preoperative chemotherapy with cisplatin (20 mg/m2/dobe; days: 1-5 i 17-21 days) and 5-FU (300 mg/m2/dobe; for 21 days). In 25 patients concurrently with chemotherapy, radiotherapy was applied in fractions (for 15 days) up to total dose of 3000 cGy. Postoperative mortality and morbidity was 15% and 50%, respectively. In the chemotherapy group, complete response (CR) rate was 4,8%, partial response (PR) was 80,9%, and stabile disease (SD) was observed in 14,3% of patients. In the chemo-/radiotherapy group the CR, PR, and SD rate were 8%, 80%, and 12%, respectively. The R0 resection rates after surgery alone, preoperative chemotherapy and chemo-/radiotherapy were 3%, 26%, and 40%, respectively. Conclusion: in patients with advanced squamous cell carcinoma of the esophagus, preoperative chemo- and/or radiotherapy improves microscopically radical resection rate, as compared to surgery alone.</description><identifier>ISSN: 1428-2526</identifier><identifier>EISSN: 1897-4309</identifier><language>eng ; pol</language><publisher>Poznan: Termedia Publishing House</publisher><ispartof>Contemporary oncology (Poznań, Poland), 2000-03, Vol.4 (2), p.80</ispartof><rights>Copyright Termedia Publishing House 2000</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1237635816?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25753,37012,44590</link.rule.ids></links><search><creatorcontrib>Dabrowski, Andrzej</creatorcontrib><creatorcontrib>Wallner, Grzegorz</creatorcontrib><creatorcontrib>Misiuna, Pawel</creatorcontrib><creatorcontrib>Polkowski, Wojciech</creatorcontrib><title>Role of the neoadjuvant therapy in the treatment of advanced carcinoma of the esophagus</title><title>Contemporary oncology (Poznań, Poland)</title><description>The aim of this study was to compare microscopically radical resection (R0) rate after surgery alone, preoperative chemotherapy, and preoperative chemo-/radiotherapy. Between 1992-1997, 101 patients were operated for squamous cell carcinoma of the esophagus. Thirty four patients were treated by surgery alone, in 42 patients surgery followed preoperative chemotherapy with cisplatin (20 mg/m2/dobe; days: 1-5 i 17-21 days) and 5-FU (300 mg/m2/dobe; for 21 days). In 25 patients concurrently with chemotherapy, radiotherapy was applied in fractions (for 15 days) up to total dose of 3000 cGy. Postoperative mortality and morbidity was 15% and 50%, respectively. In the chemotherapy group, complete response (CR) rate was 4,8%, partial response (PR) was 80,9%, and stabile disease (SD) was observed in 14,3% of patients. In the chemo-/radiotherapy group the CR, PR, and SD rate were 8%, 80%, and 12%, respectively. The R0 resection rates after surgery alone, preoperative chemotherapy and chemo-/radiotherapy were 3%, 26%, and 40%, respectively. Conclusion: in patients with advanced squamous cell carcinoma of the esophagus, preoperative chemo- and/or radiotherapy improves microscopically radical resection rate, as compared to surgery alone.</description><issn>1428-2526</issn><issn>1897-4309</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqNjE0LgkAURYcoSMr_MNBaUEfHcR1F6whaxkufqeiMzUfQv2-K2re693IOd0aCRJRFlLG4nPuepSJK85QvSWhMd43jpBA5Zywg56MakKqG2hapRAV17x4g7XtrmJ60kx9kNYId0QPvQu2VCmtaga46qUb4PaBRUws3Z9Zk0cBgMPzmimz2u9P2EE1a3R0ae-mV09KjS5KygrNcJJz9Z70AEsBDuQ</recordid><startdate>20000301</startdate><enddate>20000301</enddate><creator>Dabrowski, Andrzej</creator><creator>Wallner, Grzegorz</creator><creator>Misiuna, Pawel</creator><creator>Polkowski, Wojciech</creator><general>Termedia Publishing House</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BYOGL</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20000301</creationdate><title>Role of the neoadjuvant therapy in the treatment of advanced carcinoma of the esophagus</title><author>Dabrowski, Andrzej ; Wallner, Grzegorz ; Misiuna, Pawel ; Polkowski, Wojciech</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_12376358163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; pol</language><creationdate>2000</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dabrowski, Andrzej</creatorcontrib><creatorcontrib>Wallner, Grzegorz</creatorcontrib><creatorcontrib>Misiuna, Pawel</creatorcontrib><creatorcontrib>Polkowski, Wojciech</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>East Europe, Central Europe Database</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Contemporary oncology (Poznań, Poland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dabrowski, Andrzej</au><au>Wallner, Grzegorz</au><au>Misiuna, Pawel</au><au>Polkowski, Wojciech</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of the neoadjuvant therapy in the treatment of advanced carcinoma of the esophagus</atitle><jtitle>Contemporary oncology (Poznań, Poland)</jtitle><date>2000-03-01</date><risdate>2000</risdate><volume>4</volume><issue>2</issue><spage>80</spage><pages>80-</pages><issn>1428-2526</issn><eissn>1897-4309</eissn><abstract>The aim of this study was to compare microscopically radical resection (R0) rate after surgery alone, preoperative chemotherapy, and preoperative chemo-/radiotherapy. Between 1992-1997, 101 patients were operated for squamous cell carcinoma of the esophagus. Thirty four patients were treated by surgery alone, in 42 patients surgery followed preoperative chemotherapy with cisplatin (20 mg/m2/dobe; days: 1-5 i 17-21 days) and 5-FU (300 mg/m2/dobe; for 21 days). In 25 patients concurrently with chemotherapy, radiotherapy was applied in fractions (for 15 days) up to total dose of 3000 cGy. Postoperative mortality and morbidity was 15% and 50%, respectively. In the chemotherapy group, complete response (CR) rate was 4,8%, partial response (PR) was 80,9%, and stabile disease (SD) was observed in 14,3% of patients. In the chemo-/radiotherapy group the CR, PR, and SD rate were 8%, 80%, and 12%, respectively. The R0 resection rates after surgery alone, preoperative chemotherapy and chemo-/radiotherapy were 3%, 26%, and 40%, respectively. Conclusion: in patients with advanced squamous cell carcinoma of the esophagus, preoperative chemo- and/or radiotherapy improves microscopically radical resection rate, as compared to surgery alone.</abstract><cop>Poznan</cop><pub>Termedia Publishing House</pub><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1428-2526
ispartof Contemporary oncology (Poznań, Poland), 2000-03, Vol.4 (2), p.80
issn 1428-2526
1897-4309
language eng ; pol
recordid cdi_proquest_journals_1237635816
source Publicly Available Content Database
title Role of the neoadjuvant therapy in the treatment of advanced carcinoma of the esophagus
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T22%3A01%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20the%20neoadjuvant%20therapy%20in%20the%20treatment%20of%20advanced%20carcinoma%20of%20the%20esophagus&rft.jtitle=Contemporary%20oncology%20(Poznan%CC%81,%20Poland)&rft.au=Dabrowski,%20Andrzej&rft.date=2000-03-01&rft.volume=4&rft.issue=2&rft.spage=80&rft.pages=80-&rft.issn=1428-2526&rft.eissn=1897-4309&rft_id=info:doi/&rft_dat=%3Cproquest%3E2840256811%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_12376358163%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1237635816&rft_id=info:pmid/&rfr_iscdi=true